Société Flex Pharma Inc Nasdaq
Actions
US33938A1051
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Arthur
CEO | Chief Executive Officer | 61 | 19/07/19 |
Mark Rosenblum
DFI | Director of Finance/CFO | 70 | 10/09/19 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19/07/19 |
Nadeem Q. Mirza
PRN | Corporate Officer/Principal | - | 23/07/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Arnold Hanish
BRD | Director/Board Member | 76 | 19/07/19 |
Paul Lammers
BRD | Director/Board Member | 66 | 19/07/19 |
Jonathan Lieber
BRD | Director/Board Member | 54 | 19/06/20 |
William McVicar
CHM | Chairman | 66 | 19/07/19 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19/07/19 |
Tess Burleson
BRD | Director/Board Member | 57 | 19/07/19 |
David Arthur
CEO | Chief Executive Officer | 61 | 19/07/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 4 776 433 | 4 486 213 ( 93,92 %) | 0 | 93,92 % |
Coordonnées société
Salarius Pharmaceuticals, Inc.
2450 Holcombe Boulevard Suite X
77021, Houston
+
http://salariuspharma.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51 % | 42,75 Md | |
+48,04 % | 41,61 Md | |
+8,57 % | 41,34 Md | |
-12,36 % | 26,59 Md | |
+8,92 % | 25,49 Md | |
-25,13 % | 18,12 Md | |
+29,17 % | 12,24 Md | |
-3,12 % | 11,76 Md | |
+6,35 % | 11 Md |